Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06220721 · ClinicalTrials.gov registry record · NA
Reducing the Risk of Chronic Hypertension and Improving Vascular Function Following Preeclampsia
A NA study of Hypertension, Pregnancy Induced, sponsored by Medical College of Wisconsin.
- Recruiting
- Registry status
- NA
- Development phase
- 618
- Enrollment target
- 2
- Study locations
NCT06220721 is a NA study of Hypertension, Pregnancy Induced that is actively recruiting participants, run by Medical College of Wisconsin. The registered enrollment target is 618 participants, above the 238-participant average among 7 other Hypertension, Pregnancy Induced trials with a reported enrollment target (160% higher). The trial reports 2 study locations across 2 states.
The verdict
NCT06220721, a NA study of Hypertension, Pregnancy Induced, is actively recruiting participants, sponsored by Medical College of Wisconsin.
- RECRUITING
- Registry status
- NA
- Development phase
- 618 participants
- Enrollment target
- 2
- Study locations
Study Summary
The long-term goal of our work is to evaluate the effect of intensive postpartum blood pressure control on maternal cardiovascular health, risk of chronic hypertension, and reversal of vascular dysfunction generated by hypertensive disorders of pregnancy, thus attenuating the lifelong trajectory of cardiovascular disease risk.
Conditions Studied
Interventions
- DRUG Nifedipine ER
Study Locations (2)
Illinois
- Northwestern University - Chicago
Wisconsin
- Medical College of Wisconsin - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 618 participants |
| Start Date | 2024-10-23 |
| Est. Completion | 2029-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06220721
The ClinicalTrials.gov registry entry for NCT06220721 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 618 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 238-participant average among 7 other Hypertension, Pregnancy Induced trials with a reported enrollment target (160% higher). The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hypertension, Pregnancy Induced appearing as the primary indexed condition, and to 1 intervention - of which Nifedipine ER is the first listed.
NCT06220721 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Illinois, Wisconsin.
Frequently Asked Questions
What is clinical trial NCT06220721 about?
NCT06220721 is a clinical study titled "Reducing the Risk of Chronic Hypertension and Improving Vascular Function Following Preeclampsia". The long-term goal of our work is to evaluate the effect of intensive postpartum blood pressure control on maternal cardiovascular health, risk of chronic hypertension, and reversal of vascular dysfunction generated by hypertensive disorders of pregnancy, thus attenuating the lifelong trajectory of ...
What is the current status of trial NCT06220721?
This trial is currently recruiting. It is a NA study. The enrollment target is 618 participants. The study started on 2024-10-23. Estimated completion is 2029-06-30.
What conditions does trial NCT06220721 study?
This clinical trial studies the following conditions: Hypertension, Pregnancy Induced.
What interventions are being tested in trial NCT06220721?
The interventions under investigation include: Nifedipine ER (DRUG).
Who is sponsoring clinical trial NCT06220721?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06220721 being conducted?
This trial has 2 study locations across Illinois, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension, Pregnancy Induced
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Enhancing Care & Outcomes for Patients During the First Postpartum Year
RECRUITING · NA
-
Randomized Controlled Trial of Two Mobile Health Strategies to Manage Postpartum Hypertension
RECRUITING · NA
-
Optimizing Cardiovascular Preventive Care for Women Following Hypertensive Disorders of Pregnancy
RECRUITING · NA
-
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
RECRUITING · NA
-
Better Understanding Patient Perspectives of an Educational Tool for Postpartum Hypertensive Patients
ACTIVE NOT RECRUITING · NA
-
Innovation in Postpartum Care for Women With Hypertensive Disorders of Pregnancy
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.